Diego Alvarado
0000-0002-5878-1730
3 papers found
Refreshing results…
Anti‐KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria
An antibody-drug conjugate directed to the ALK receptor demonstrates efficacy in preclinical models of neuroblastoma
ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC
Missing publications? Search for publications with a matching author name.